These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14265292)

  • 1. CYTOTOXIC ACTIVITY COMPARED WITH PHOTOMETRIC MEASUREMENTS OF SELECTED ALKYLATING AGENTS.
    SANDERSON RP; MCKENNA JM; BLAKEMORE WS
    Nature; 1965 Jan; 205():479-81. PubMed ID: 14265292
    [No Abstract]   [Full Text] [Related]  

  • 2. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 3. THE TREATMENT OF CANCER BY ISOLATION PERFUSION.
    DONALDSON SS; FLETCHER WS
    Am J Nurs; 1964 Aug; 64():81-4. PubMed ID: 14180364
    [No Abstract]   [Full Text] [Related]  

  • 4. CURRENT STATUS OF CHEMOTHERAPY OF CANCER.
    KREMENTZ ET; KOKAME GM; IGLESIAS F
    Postgrad Med; 1964 Apr; 35():384-94. PubMed ID: 14131637
    [No Abstract]   [Full Text] [Related]  

  • 5. REDUCTION OF THE TOXICITY OF 'RADIOMIMETIC' ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. 3. THE MECHANISM OF THE PROTECTIVE ACTION OF THIOSULPHATE.
    CONNORS TA; JENEY A; JONES M
    Biochem Pharmacol; 1964 Dec; 13():1545-50. PubMed ID: 14248383
    [No Abstract]   [Full Text] [Related]  

  • 6. COLORIMETRIC METHOD FOR DETERMINATION OF URACIL MUSTARD AND RELATED ALKYLATING AGENTS.
    PETERING HG; VANGIESSEN GJ
    J Pharm Sci; 1963 Dec; 52():1159-62. PubMed ID: 14088966
    [No Abstract]   [Full Text] [Related]  

  • 7. DENTAL LESIONS IN RAT INDUCED BY RADIOMIMETIC AGENTS.
    HEBBORN P; MISHRA LC; DALTON C; WILLIAMS JP
    Arch Pathol; 1965 Aug; 80():110-5. PubMed ID: 14326433
    [No Abstract]   [Full Text] [Related]  

  • 8. CHLORAMBUCIL-PREDNISOLONE THERAPY FOR DISSEMINATED BREAST CARCINOMA.
    FRECKMAN HA; FRY HL; MENDEZ FL; MAURER ER
    JAMA; 1964 Jul; 189():23-6. PubMed ID: 14149018
    [No Abstract]   [Full Text] [Related]  

  • 9. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 10. COMPARISON OF THE EFFECTS OF SOME RADIATION MODIFIERS ON SELECTED RADIOMIMETIC AGENTS IN MICROORGANISMS.
    PITTILLO RF; NARKATES AJ; BURNS J
    Radiat Res; 1965 Jun; 25():401-9. PubMed ID: 14295129
    [No Abstract]   [Full Text] [Related]  

  • 11. ANTI-MESODERMAL ACTIVITY OF A NITROGEN MUSTARD DERIVATIVE.
    JURAND A
    J Embryol Exp Morphol; 1963 Dec; 11():689-96. PubMed ID: 14081989
    [No Abstract]   [Full Text] [Related]  

  • 12. CANCER CHEMOTHERAPY.
    EISMAN SG; RICHARDSON FM
    Med Sci; 1964 Mar; 15():63-72. PubMed ID: 14143132
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF ALKYLATING AGENTS AND WHOLE-BODY X-IRRADIATION ON THYMUS.
    HERRANEN A
    Nature; 1964 Aug; 203():891-2. PubMed ID: 14204093
    [No Abstract]   [Full Text] [Related]  

  • 14. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE.
    ABELL CW; FALK HL; SHIMKIN MB; WEISBURGER EK; WEISBURGER JH; GUBAREFF N
    Science; 1965 Mar; 147(3664):1443-5. PubMed ID: 14268720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FACTORS INFLUENCING THE METABOLISM OF NITROGEN MUSTARD IN BLOOD AND BLOOD COMPONENTS: CORRELATION OF COLORIMETRIC MEASUREMENT WITH BIOLOGIC TOXICITY.
    SKINNER DB; HERBST AL; RAKER JW
    Ann Surg; 1964 Jul; 160(1):26-32. PubMed ID: 14183087
    [No Abstract]   [Full Text] [Related]  

  • 16. ALKYLATING AGENTS DERIVED FROM INDOLES. IV. SYNTHESIS OF THE 5-NITROGEN MUSTARD OF INDOLE-3-CARBOXYLIC ACID.
    DEGRAW J; GOODMAN L
    J Med Chem; 1964 Mar; 7():213-5. PubMed ID: 14187378
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL; SALVIN LG; SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
    [No Abstract]   [Full Text] [Related]  

  • 18. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 19. FACTORS INFLUENCING THE METABOLISM OF NITROGEN MUSTARD IN BLOOD AND BLOOD COMPONENTS. CORRELATION OF COLORIMETRIC MEASUREMENT WITH BIOLOGIC TOXICITY.
    SKINNER DB; HERBST AL; RAKER JW
    Bull Soc Int Chir; 1964; 23():63-74. PubMed ID: 14139418
    [No Abstract]   [Full Text] [Related]  

  • 20. INTRALYMPHATIC CHEMOTHERAPY WITH CYTOTOXIC DRUGS IN RABBITS.
    MCCARTHY JJ; O'MALLEY E; FITZGERALD P
    Br J Surg; 1964 Jul; 51():542-4. PubMed ID: 14199070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.